Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Dauntless who wrote (1499)	1/6/1998 1:04:00 PM
From: Jumper	Respond to of 7041

Re: Redneck Remarks v. Stock Price See you in the great state of Texas -3/8 We will eat your dog Billy Wexler -7/8 That tricky Asholio (grrrrrrrr) -5/8 Zona is being accumulated -1 1/4

To: Dauntless who wrote (1499)	1/6/1998 1:59:00 PM
From: Bill Wexler	Read Replies (1) \| Respond to of 7041

Zonagen does not have an effective ED solution. The company has done nothing except screw small investors. The stock is going to 0...and rightly so.

To: Dauntless who wrote (1499)	1/6/1998 9:01:00 PM
From: BDR	Read Replies (2) \| Respond to of 7041

<<Also, back to statistics, would an MD consider Vasomax's response rate of 40% vs. the placebo's 17% to be a 23% or a 135% increase in response?>> 17%. I thought it was a response rate of 44% v. 25% for placebo which isn't a big improvement. Regardless of the placebo response, it means that even in the controlled environment of a study less than half the patients got the desired result. Somehow the studies by academics always show better results than we poor slobs out in the trenches get with our patients so I would predict that about a third would respond. That means two thirds are going to waste their time and money. I would like to see better odds since I am the guy who has to deal face to face with the patient.